Latest filing published 13 Apr 2021 for OnKure Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -79.1%Entry US$123.20 · Close at T+365 US$25.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
RiverVest Venture Fund III, L.P.: trading record in brief
RiverVest Venture Fund III, L.P. discloses dealings in 3 companies, chiefly Allakos Inc., OnKure Therapeutics, Inc. and Spruce Biosciences, Inc. The record holds 35 filings, for trades running from 23 July 2018 to 9 April 2021.
Both buying and selling appear: 3 purchases worth €7.4M, against 26 sales worth €91.1M. Sales outweigh purchases by €83.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2021 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €2.5M. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 13 April 2021, reports a transaction in OnKure Therapeutics, Inc. The latest purchase dates back some time: it was published 2,036 days ago, on 13 April 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to RiverVest Venture Fund III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,100,765 sharesCommon StockSEC:0000899243-21-015634:0
- 829,113 sharesCommon StockSEC:0000899243-21-015634:1
- 200,000 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-21-015634:2Canonical exit: 8 Jul 2021 (T+90)
- 862,574 shares0Common StockSEC:0000899243-21-001187:0
- 1,070,172 sharesCommon StockSEC:0000899243-20-028479:0
- 828,109 sharesCommon StockSEC:0000899243-20-028479:1
- ▲
Same trade as the filing by Moghrabi Dina Chaya, counted once
4M USD31SEC250,000 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-20-028479:2Canonical exit: 12 Jan 2021 (T+90) - 1,150,000 shares@ US$71.04100.0% of flowCommon StockSEC:0000899243-20-013117:0
- 31,400 shares@ US$39.621.2% of flowCommon StockSEC:0000899243-19-016233:0
- 7,100 shares@ US$40.580.3% of flowCommon StockSEC:0000899243-19-016233:1
- 232 shares@ US$41.050.0% of flowCommon StockSEC:0000899243-19-016233:2
- 900 shares@ US$40.400.0% of flowCommon StockSEC:0000899243-19-015869:0
- 21,194 shares@ US$39.500.8% of flowCommon StockSEC:0000899243-19-015869:1
- 6,248 shares@ US$39.490.2% of flowCommon StockSEC:0000899243-19-015869:2
- 17,500 shares@ US$39.810.7% of flowCommon StockSEC:0000899243-19-015869:3
- 47,893 shares@ US$40.011.8% of flowCommon StockSEC:0000899243-19-015869:4
- 600 shares@ US$43.270.0% of flowCommon StockSEC:0000899243-19-015407:0
- 7,079 shares@ US$40.060.3% of flowCommon StockSEC:0000899243-19-015407:1
- 17,321 shares@ US$39.120.7% of flowCommon StockSEC:0000899243-19-015407:2
- 4,257 shares@ US$40.160.2% of flowCommon StockSEC:0000899243-19-015407:3
- 22,049 shares@ US$39.630.8% of flowCommon StockSEC:0000899243-19-015407:4
- 2,600 shares@ US$38.970.1% of flowCommon StockSEC:0000899243-19-015407:5
- 22,679 shares@ US$37.230.8% of flowCommon StockSEC:0000899243-19-010916:0
- 7,321 shares@ US$36.800.3% of flowCommon StockSEC:0000899243-19-010916:1
- 35,889 shares@ US$36.331.2% of flowCommon StockSEC:0000899243-19-010916:2
25 of 34 declarations
